View our financial updates, reports and presentations, together with stock exchange announcements and information for shareholders.
Latest results and annual report
Preliminary results for the year ended 31 December 2019
We reported 2019 financial performance ahead of expectations, with strong operational delivery, as we continue to execute our strategy to become an industry-leading specialist inhalation CDMO.
The latest from the LSE
Follow our share price at-a-glance here, with updates every 15 minutes from the London Stock Exchange (LSE). You can also access more detailed share price information on the link below.